Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model

Tongyu Wikramanayake, Alexandra C. Villasante, Lucia M. Mauro, Carmen I. Perez, Lawrence A Schachner, Joaquin J Jimenez

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Alopecia areata (AA) is an autoimmune nonscarring hair loss disorder. AA can be acute, recurrent, or chronic. Current therapeutic options for AA are limited, and there is no effective prevention for recurrent AA. We have previously shown a correlation between the expression of HSP70 (HSPA1A/B), a heat shock protein involved in the inflammatory response, and the onset of AA in the C3H/ HeJ mouse model. In this study, we tested the effects of quercetin, a bioflavonoid with anti-inflammatory properties, on AA development and HSP70 expression in the C3H/HeJ model. Mice with spontaneous AA were treated with subcutaneous quercetin or sham injections. Hair regrowth was observed in lesional areas in all the quercetin-treated mice, but in none of the sham-treated mice. In addition, non-alopecic C3H/HeJ mice were heat-treated to induce alopecia, along with quercetin or sham injections. Whereas 24% of the heat-treated mice with sham injections developed alopecia, none of the mice receiving quercetin injections did. As expected, the level of HSP70 expression in quercetin-treated areas was comparable to control. Furthermore, we showed that systemic delivery of quercetin by intraperitoneal injections prevented/reduced spontaneous onset of AA. Our results demonstrated that quercetin provided effective treatment for AA as well as prevention of onset of AA in the C3H/HeJ model, and warrant further clinical studies to determine whether quercetin may provide both treatment for preexisting AA and prevention of recurrent AA. The ready availability of quercetin as a dietary supplement may lead to increased patient compliance and positive outcomes for AA.

Original languageEnglish
Pages (from-to)267-274
Number of pages8
JournalCell Stress and Chaperones
Volume17
Issue number2
DOIs
StatePublished - Mar 1 2012

Fingerprint

Alopecia Areata
Inbred C3H Mouse
Quercetin
Therapeutics
Alopecia
Injections
Dietary supplements
Hot Temperature
Heat-Shock Proteins
Flavonoids
Patient Compliance
Anti-Inflammatory Agents
Dietary Supplements
Intraperitoneal Injections
Availability
Hair

Keywords

  • Alopecia areata
  • C3H/HeJ
  • Heatshock
  • HSP70
  • Quercetin

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model. / Wikramanayake, Tongyu; Villasante, Alexandra C.; Mauro, Lucia M.; Perez, Carmen I.; Schachner, Lawrence A; Jimenez, Joaquin J.

In: Cell Stress and Chaperones, Vol. 17, No. 2, 01.03.2012, p. 267-274.

Research output: Contribution to journalArticle

@article{dd5a65e752044aab999728ac115746ac,
title = "Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model",
abstract = "Alopecia areata (AA) is an autoimmune nonscarring hair loss disorder. AA can be acute, recurrent, or chronic. Current therapeutic options for AA are limited, and there is no effective prevention for recurrent AA. We have previously shown a correlation between the expression of HSP70 (HSPA1A/B), a heat shock protein involved in the inflammatory response, and the onset of AA in the C3H/ HeJ mouse model. In this study, we tested the effects of quercetin, a bioflavonoid with anti-inflammatory properties, on AA development and HSP70 expression in the C3H/HeJ model. Mice with spontaneous AA were treated with subcutaneous quercetin or sham injections. Hair regrowth was observed in lesional areas in all the quercetin-treated mice, but in none of the sham-treated mice. In addition, non-alopecic C3H/HeJ mice were heat-treated to induce alopecia, along with quercetin or sham injections. Whereas 24{\%} of the heat-treated mice with sham injections developed alopecia, none of the mice receiving quercetin injections did. As expected, the level of HSP70 expression in quercetin-treated areas was comparable to control. Furthermore, we showed that systemic delivery of quercetin by intraperitoneal injections prevented/reduced spontaneous onset of AA. Our results demonstrated that quercetin provided effective treatment for AA as well as prevention of onset of AA in the C3H/HeJ model, and warrant further clinical studies to determine whether quercetin may provide both treatment for preexisting AA and prevention of recurrent AA. The ready availability of quercetin as a dietary supplement may lead to increased patient compliance and positive outcomes for AA.",
keywords = "Alopecia areata, C3H/HeJ, Heatshock, HSP70, Quercetin",
author = "Tongyu Wikramanayake and Villasante, {Alexandra C.} and Mauro, {Lucia M.} and Perez, {Carmen I.} and Schachner, {Lawrence A} and Jimenez, {Joaquin J}",
year = "2012",
month = "3",
day = "1",
doi = "10.1007/s12192-011-0305-3",
language = "English",
volume = "17",
pages = "267--274",
journal = "Cell Stress and Chaperones",
issn = "1355-8145",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model

AU - Wikramanayake, Tongyu

AU - Villasante, Alexandra C.

AU - Mauro, Lucia M.

AU - Perez, Carmen I.

AU - Schachner, Lawrence A

AU - Jimenez, Joaquin J

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Alopecia areata (AA) is an autoimmune nonscarring hair loss disorder. AA can be acute, recurrent, or chronic. Current therapeutic options for AA are limited, and there is no effective prevention for recurrent AA. We have previously shown a correlation between the expression of HSP70 (HSPA1A/B), a heat shock protein involved in the inflammatory response, and the onset of AA in the C3H/ HeJ mouse model. In this study, we tested the effects of quercetin, a bioflavonoid with anti-inflammatory properties, on AA development and HSP70 expression in the C3H/HeJ model. Mice with spontaneous AA were treated with subcutaneous quercetin or sham injections. Hair regrowth was observed in lesional areas in all the quercetin-treated mice, but in none of the sham-treated mice. In addition, non-alopecic C3H/HeJ mice were heat-treated to induce alopecia, along with quercetin or sham injections. Whereas 24% of the heat-treated mice with sham injections developed alopecia, none of the mice receiving quercetin injections did. As expected, the level of HSP70 expression in quercetin-treated areas was comparable to control. Furthermore, we showed that systemic delivery of quercetin by intraperitoneal injections prevented/reduced spontaneous onset of AA. Our results demonstrated that quercetin provided effective treatment for AA as well as prevention of onset of AA in the C3H/HeJ model, and warrant further clinical studies to determine whether quercetin may provide both treatment for preexisting AA and prevention of recurrent AA. The ready availability of quercetin as a dietary supplement may lead to increased patient compliance and positive outcomes for AA.

AB - Alopecia areata (AA) is an autoimmune nonscarring hair loss disorder. AA can be acute, recurrent, or chronic. Current therapeutic options for AA are limited, and there is no effective prevention for recurrent AA. We have previously shown a correlation between the expression of HSP70 (HSPA1A/B), a heat shock protein involved in the inflammatory response, and the onset of AA in the C3H/ HeJ mouse model. In this study, we tested the effects of quercetin, a bioflavonoid with anti-inflammatory properties, on AA development and HSP70 expression in the C3H/HeJ model. Mice with spontaneous AA were treated with subcutaneous quercetin or sham injections. Hair regrowth was observed in lesional areas in all the quercetin-treated mice, but in none of the sham-treated mice. In addition, non-alopecic C3H/HeJ mice were heat-treated to induce alopecia, along with quercetin or sham injections. Whereas 24% of the heat-treated mice with sham injections developed alopecia, none of the mice receiving quercetin injections did. As expected, the level of HSP70 expression in quercetin-treated areas was comparable to control. Furthermore, we showed that systemic delivery of quercetin by intraperitoneal injections prevented/reduced spontaneous onset of AA. Our results demonstrated that quercetin provided effective treatment for AA as well as prevention of onset of AA in the C3H/HeJ model, and warrant further clinical studies to determine whether quercetin may provide both treatment for preexisting AA and prevention of recurrent AA. The ready availability of quercetin as a dietary supplement may lead to increased patient compliance and positive outcomes for AA.

KW - Alopecia areata

KW - C3H/HeJ

KW - Heatshock

KW - HSP70

KW - Quercetin

UR - http://www.scopus.com/inward/record.url?scp=84863580746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863580746&partnerID=8YFLogxK

U2 - 10.1007/s12192-011-0305-3

DO - 10.1007/s12192-011-0305-3

M3 - Article

C2 - 22042611

AN - SCOPUS:84863580746

VL - 17

SP - 267

EP - 274

JO - Cell Stress and Chaperones

JF - Cell Stress and Chaperones

SN - 1355-8145

IS - 2

ER -